Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Severe vertigo; Numbness of hands and fingers; Severe headache; This non-serious case was reported by a consumer and described the occurrence of vertigo in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included migraine and vertigo. Concurrent medical conditions included arthritis (of the spine with bone spurs thereon) and anxiety. Concomitant products included escitalopram. On 03-SEP-2025, the patient received Shingrix. On 05-SEP-2025, 2 days after receiving Shingrix, the patient experienced vertigo (Verbatim: Severe vertigo), numbness in hand (Verbatim: Numbness of hands and fingers) and headache (Verbatim: Severe headache). On 06-SEP-2025, the outcome of the vertigo and headache were resolved (duration 1 day) and the outcome of the numbness in hand was resolved. It was unknown if the reporter considered the vertigo, numbness in hand and headache to be related to Shingrix. It was unknown if the company considered the vertigo, numbness in hand and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 08-SEP-2025 The patient had severe vertigo, numbness of hands and fingers and severe headache.
Anxiety; Arthritis (of the spine with bone spurs thereon)
Medical History/Concurrent Conditions: Migraine; Vertigo
ESCITALOPRAM